Sathyen A. Prabhu

616 total citations
12 papers, 454 citations indexed

About

Sathyen A. Prabhu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Sathyen A. Prabhu has authored 12 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Sathyen A. Prabhu's work include Histone Deacetylase Inhibitors Research (5 papers), Fibroblast Growth Factor Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Sathyen A. Prabhu is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Fibroblast Growth Factor Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Sathyen A. Prabhu collaborates with scholars based in United States, Canada and Jordan. Sathyen A. Prabhu's co-authors include Mohamed R. Akl, Betty Tai, Nehad M. Ayoub, André Goy, K. Stephen Suh, Poonam Nagpal, Chhavi Sharma, Munawwar Ali Khan, Arif Hussain and Sonia V. del Rincón and has published in prestigious journals such as Blood, Oncogene and Clinical Cancer Research.

In The Last Decade

Sathyen A. Prabhu

12 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sathyen A. Prabhu United States 9 321 94 69 61 57 12 454
Mathew Loesch United States 9 305 1.0× 142 1.5× 66 1.0× 51 0.8× 55 1.0× 13 469
Chul-Ho Jeong South Korea 9 546 1.7× 133 1.4× 72 1.0× 47 0.8× 33 0.6× 12 652
Jung Yoo South Korea 14 400 1.2× 122 1.3× 107 1.6× 51 0.8× 40 0.7× 19 529
Jiajun Yap Singapore 7 329 1.0× 101 1.1× 76 1.1× 28 0.5× 32 0.6× 11 477
Z. Peter Wang China 14 390 1.2× 121 1.3× 128 1.9× 41 0.7× 31 0.5× 18 524
Anping Song China 10 306 1.0× 99 1.1× 95 1.4× 97 1.6× 64 1.1× 15 527
Marco Mazzoletti Italy 9 413 1.3× 182 1.9× 97 1.4× 56 0.9× 27 0.5× 11 543
Tienian Zhu China 13 279 0.9× 118 1.3× 128 1.9× 61 1.0× 68 1.2× 27 460
Gaoyang Zhu China 9 323 1.0× 115 1.2× 95 1.4× 31 0.5× 30 0.5× 14 486

Countries citing papers authored by Sathyen A. Prabhu

Since Specialization
Citations

This map shows the geographic impact of Sathyen A. Prabhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sathyen A. Prabhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sathyen A. Prabhu more than expected).

Fields of papers citing papers by Sathyen A. Prabhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sathyen A. Prabhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sathyen A. Prabhu. The network helps show where Sathyen A. Prabhu may publish in the future.

Co-authorship network of co-authors of Sathyen A. Prabhu

This figure shows the co-authorship network connecting the top 25 collaborators of Sathyen A. Prabhu. A scholar is included among the top collaborators of Sathyen A. Prabhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sathyen A. Prabhu. Sathyen A. Prabhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Moussa, Omar, Christophe Gonçalves, Vincent R. Richard, et al.. (2024). Combined Inhibition of MNK Signaling and BET Proteins Reveals TGM2 as a Novel Vulnerability in Melanoma. Journal of Investigative Dermatology. 145(4). 979–984.e5. 1 indexed citations
2.
Dahabieh, Michael S., Fan Huang, Christophe Gonçalves, et al.. (2021). Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance. Autophagy. 18(3). 540–558. 14 indexed citations
3.
Khoury, Elie, Qianyu Guo, Sathyen A. Prabhu, et al.. (2020). MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression. Oncogene. 39(18). 3650–3665. 19 indexed citations
4.
Prabhu, Sathyen A., Omar Moussa, Wilson H. Miller, & Sonia V. del Rincón. (2020). The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma. International Journal of Molecular Sciences. 21(11). 4055–4055. 24 indexed citations
5.
Lue, Jennifer Kimberly, Sathyen A. Prabhu, Yuxuan Liu, et al.. (2019). Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas. Clinical Cancer Research. 25(17). 5271–5283. 59 indexed citations
6.
Lue, Jennifer Kimberly, Sathyen A. Prabhu, Yuxuan Liu, et al.. (2017). DUAL INHIBITION OF EZH2 AND HDAC IS SYNERGISTIC IN EZH2 DYSREGULATED LYMPHOMAS. Hematological Oncology. 35(S2). 254–255. 3 indexed citations
7.
Amengual, Jennifer E., Sathyen A. Prabhu, Maximilian Lombardo, et al.. (2016). Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib. Clinical Cancer Research. 23(12). 3084–3096. 24 indexed citations
8.
Lue, Jennifer Kimberly, Sathyen A. Prabhu, Yuxuan Liu, Owen A. O’Connor, & Jennifer E. Amengual. (2016). Epigenetic Targeting with EZH2 and HDAC Inhibitors Is Synergistic in EZH2 Deregulated Lymphomas. Blood. 128(22). 839–839. 5 indexed citations
9.
Akl, Mohamed R., Poonam Nagpal, Nehad M. Ayoub, et al.. (2016). Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies. Oncotarget. 7(28). 44735–44762. 147 indexed citations
10.
Akl, Mohamed R., Poonam Nagpal, Nehad M. Ayoub, et al.. (2015). Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine. Oncotarget. 6(30). 28693–28715. 63 indexed citations
11.
Hussain, Arif, et al.. (2013). Sulforaphane Inhibits Growth of Human Breast Cancer Cells and Augments the Therapeutic Index of the Chemotherapeutic Drug, Gemcitabine. Asian Pacific Journal of Cancer Prevention. 14(10). 5855–5860. 43 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mathew Loesch Breakdown of academic impact, for papers by Chul-Ho Jeong Breakdown of academic impact, for papers by Jung Yoo Breakdown of academic impact, for papers by Jiajun Yap Breakdown of academic impact, for papers by Z. Peter Wang Breakdown of academic impact, for papers by Anping Song Breakdown of academic impact, for papers by Marco Mazzoletti Breakdown of academic impact, for papers by Tienian Zhu Breakdown of academic impact, for papers by Gaoyang Zhu
Rankless by CCL
2026